Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia
- 30 April 2003
- journal article
- review article
- Published by Elsevier BV in Seminars in Oncology
- Vol. 30 (2), 116-120
- https://doi.org/10.1053/sonc.2003.50038
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Prognostic factors in symptomatic Waldenstrom's macroglobulinemiaSeminars in Oncology, 2003
- Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 casesBritish Journal of Haematology, 2001
- Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patientsAnnals of Hematology, 2001
- Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003)Blood, 2001
- Waldenström’s Macroglobulinemia: Clinical Features, Complications, and ManagementJournal of Clinical Oncology, 2000
- Waldenström's macroglobulinemiaCancer, 1997
- Study of prognosis in Waldenstrom's macroglobulinemia: a proposal for a simple binary classification with clinical and investigational utilityBlood, 1994
- Waldenstrom's macroglobulinemiaBlood, 1994
- Prognostic factors in Waldenström's macroglobulinemia: a report of 167 cases.Journal of Clinical Oncology, 1993
- To treat or not to treat, this is the real questionLeukemia Research, 1991